-
PepGen Announces Appointment of Two New Directors to its Board
31 Mar 2025 20:31 GMT
… multiple companies, including Adverum Biotechnologies, Cell Genesys, CODA Biotherapeutics, the Gencell division …
-
KSQ Therapeutics Appoints Kristen Hege, M.D., to its Board of Directors
05 Mar 2025 12:00 GMT
… executive roles in biotech at Cell Genesys, Cellerant, and Theraclone. Dr. Hege …
-
EvolveImmune Appoints Kristen M. Hege, M.D. to Its Board of Directors
11 Feb 2025 13:00 GMT
… similar roles at Celgene and Cell Genesys. Dr. Hege spent more than …
-
Hinge Bio Raises $30 Million Series A’ Financing to Develop Next-Generation Therapies via its Proprietary GEM-DIMER Platform
15 Jan 2025 12:00 GMT
… Receptors for T cell therapy (Cell Genesys, Inc.), and genetically-modified mice …
-
Hinge Bio Presents Preclinical Data from its GEM-DIMER™ Programs Targeting B Cell Depletion at the American College of Rheumatology (ACR) Convergence 2024
14 Nov 2024 12:00 GMT
… Receptors for T cell therapy (Cell Genesys, Inc.), and genetically-modified mice …
-
Genenexer who sold two startups for $1 billion each named CEO of CuraSen Therapeutics
15 Oct 2024 21:59 GMT
… until 1990 and CFO at Cell Genesys before spending 12 years at …
-
CuraSen Therapeutics Appoints Kathleen Sereda Glaub Chief Executive Officer
15 Oct 2024 13:25 GMT
… and chief financial officer of Cell Genesys, treasurer of Genentech, and various …
-
Global Cancer Gene Therapy Market Set for Significant Growth, Projected to Reach USD 3,142.2 Million by 2034 Driven by Personalized Medicine and Targeted Therapies | Future Market Insights, Inc.
14 Oct 2024 13:30 GMT
… AB
Amgen
Bristol-Myers Squibb
Cell Genesys Inc.
Adaptimmune Therapeutics plc.
Achieve …
-
Hinge Bio, Inc. Chief Scientific Officer, Daniel Capon, Ph.D., to Present its GEM-DIMER™ Platform Technology at the University of Oxford, Kennedy Institute of Rheumatology’s Annual Translational Research Conference
14 Aug 2024 12:00 GMT
… Receptors for T cell therapy (Cell Genesys, Inc.), and genetically-modified mice …
-
PureTech Announces Change of Board Role
20 Jun 2024 06:14 GMT
… Amgen for $2.2 billion), Cell Genesys and Millennium Pharmaceuticals (acquired by …